Neurocrine Biosciences Inc Q1 adjusted earnings Miss Estimates

Neurocrine Biosciences Inc (NBIX) reported earnings for first quarter that dropped from the same period last year.

The company's bottom line came in at $32.1 million, or $0.33 per share. This compares with $37.4 million, or $0.39 per share, in last year's first quarter.

Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $47.9 million or $0.49 per share for the period.

Analysts had expected the company to earn $0.51 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter fell 0.2% to $236.6 million from $237.1 million last year.

Neurocrine Biosciences Inc earnings at a glance:

-Earnings (Q1): $47.9 Mln. vs. $79.1 Mln. last year.
-EPS (Q1): $0.49 vs. $0.82 last year.
-Analysts Estimate: $0.51
-Revenue (Q1): $236.6 Mln vs. $237.1 Mln last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT